SAM #26-004263

Sole Source Procurement – BioMerieux Reagents and Supplies for NIH Clinical Center

This opportunity involves the NIH Clinical Center's intent to sole source a one-year supply of BioMerieux reagents and supplies for mycoplasma testing and routine laboratory work. - Sole source procurement to BioMerieux Inc. for reagents and supplies - Supports mycoplasma testing and routine laboratory operations - Required for compatibility with existing validated BioMerieux instrumentation - Meets cGMP regulatory standards for sterility testing and environmental monitoring - No other OEMs, vendors, or part numbers specified - Acquisition under FAR Part 13 Simplified Acquisition Procedures - No competition due to unique requirements for BioMerieux products - Place of performance and delivery: NIH Clinical Center, Bethesda, MD - Period of performance: One-year supply (annual procurement)

Description

This acquisition is for one year’s supply of reagents and supplies from BioMerieux for mycoplasma testing and routine lab work to support the National Institutes of Health cGMP program and the NIH Clinical Center patients.

•             Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

•             NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•             Place of Performance: Bethesda, MD 20892 USA

POTS: 26-004263

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to BioMeriux Inc., located at 515 S Colorow Dr, Salt Lake City, UT 84108, on a firm fixed price sole source award basis to provide  reagents to the National Institutes of Health.

The reagents and supplies requested from BioMerieux are specific for the existing instrumentation and clinical tests which have undergone rigorous laboratory validation. These reagents and supplies are therefore the only ones that can meet the regulatory cGMP standards for product sterility testing and environmental monitoring in DLM.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by April 21, 2026 at 12pm EST.

View original listing